Life Science Company News

MedTainer Adopted by 12 LPs; US Market Next in Line

CORONA, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced today that 3 more Canadian Licensed Producers have adopted the MedTainer™ , bringing the number of LPs using MedTainers as either a packaging or promotional unit to 12. These include Organigram, Aphria, Tilray, Aurora, CANNMART, James E. Wagner Cultivation and 6 other major LPs.

It has been the company’s goal to provide a compliant, child-safe pre-packaging solution for cultivators to successfully inventory fresh cannabis. MedTainer is very close to achieving that goal and intends to announce which of the LPs will begin utilizing the MedTainer in other ways than promotion or direct retail in the very near future. LPs are seeing the Medtainer as an innovative, multi-functional container that can be featured in retail establishments, including large pharmacy chains and box stores.

The US will probably change the current Schedule 1 designation for cannabis, possibly by late this spring. Many of the Canadian operators that MedTainer Inc. is doing business with already have distribution networks prepared and, in some cases, operating in the US. Since the potential of that market is 10 times as large as the Canadian market MedTainer Inc. is in a unique position to dominate the US pre-packaging and retail market, having worked hard to anticipate what US Federal compliancy issues would be and proving what might be that business model in Canada with its LP partners.     

For investor or sales information please visit MedTainer Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

MedTainer Inc. trades on the OTC under the call letters MDTR. The company’s websites are www.Medtainerinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for MedTainer can be taken online and by phone. Custom orders are especially welcome.  Please send all inquiries to info@MedTainerinc.com or call 844-226-5649. Ask for Jack Rein, National Services Director.  MedTainer Inc. can also be accessed through Twitter and Instagram at @MedTainerinc

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.

By: Nasdaq / GlobeNewswire - 18 Mar 2019
Back to overview

Enhance your business development with Biotechgate